Adult Dosing
Seasonal allergic rhinitis, perennial allergic rhinitis, chronic idiopathic urticaria
- 5 mg or 2 teaspoonfuls (5 mg in 10 mL) PO qd
Note:
- ODT should be placed on the tongue and allowed to disintegrate before swallowing; administer with or without water
- Syrup should be administered with a commercially available measuring dropper or syringe that is calibrated to deliver 2 mL and 2.5 mL (half teaspoon)
Pediatric Dosing
- Safety and effectiveness in pediatric patients <6 months of age have not been established
Seasonal allergic rhinitis, perennial allergic rhinitis, chronic idiopathic urticaria
12 yrs: 5 mg or 2 teaspoonfuls (5 mg in 10 mL) PO qd- 6-11 yrs: 2.5 mg or 1 teaspoonful (2.5 mg in 5 mL) PO qd
- 1-5 yrs: Half teaspoonful (1.25 mg in 2.5 mL) PO qd
- 6-11 months: 2 mL (1 mg) PO qd
Notes:- ODT should be placed on the tongue and allowed to disintegrate before swallowing; administer with or without water
- Syrup should be administered with a commercially available measuring dropper or syringe that is calibrated to deliver 2 mL and 2.5 mL (half teaspoon)
See Supplemental Patient Information
- Hypersensitivity reactions such as rash, pruritus, urticaria, edema, dyspnea, and anaphylaxis have occurred rarely after administration of the drug; discontinue the drug and prefer alternate therapy if such reaction occurs
- Dose selection should be cautiously done in elderly patients, reflecting the greater frequency of decreased hepatic, renal, or cardiac function and of concomitant disease or other drug therapy
Cautions: Use cautiously in
- Renal impairment
- Hepatic impairment
- Phenylketonurics (phenylalanine-containing forms)
Supplemental Patient Information
- Advise patients not to increase the dose or dosing frequency as it does not increase effectiveness at higher doses and may cause somnolence
Pregnancy Category:C
Breastfeeding: Unlikely to affect breastfed infant or milk production because of its low milk levels and lack of sedation and anticholinergic effects. When used in combination with a sympathomimetic agent such as pseudoephedrine, it may produce a negative effect on lactation. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 12 April 2011). As per manufacturer's data, a decision should be made whether to discontinue nursing or to discontinue the drug, analyzing the importance of the drug to the mother.
Pricing data from www.DrugStore.com in U.S.A.
- Clarinex 0.5 MG/ML SYRP [Bottle] (SCHERING)
473 ml = $238.58
1419 ml = $683.68 - Clarinex Reditabs 2.5 MG TBDP [Box] (SCHERING)
30 mg = $164.99
90 mg = $486.99 - Clarinex 5 MG TABS [Bottle] (SCHERING)
30 mg = $152.99
90 mg = $435.96
Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.
